Inventor · disambiguated record
Joseph Collard
Also filed as: COLLARD JOSEPH
112 granted patents·19 pending applications·214 citations·filing 2009–2021
99Inventor score
Top patents by PatentIndex Score
131 records- 0193US8318690B2Treatment of hemoglobin (HBF/HBG) related diseases by inhibition of natural antisense transcript to HBF/HBGCOLLARD JOSEPH·Filed 2010·Granted Nov 27, 2012·27 cites·20 claims
- 0292US9771579B2Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNACOLLARD JOSEPH·Filed 2011·Granted Sep 26, 2017·22 cites·12 claims
- 0392US9410155B2Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGFCURNA INC·Filed 2014·Granted Aug 9, 2016·14 cites·12 claims
- 0490US9593330B2Treatment of frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXNCOLLARD JOSEPH·Filed 2012·Granted Mar 14, 2017·12 cites·15 claims
- 0590US9012139B2Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to DMD familyCOLLARD JOSEPH·Filed 2010·Granted Apr 21, 2015·13 cites·11 claims
- 0687US9382538B2Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3CURNA INC·Filed 2015·Granted Jul 5, 2016·5 cites·16 claims
- 0785US11697814B2Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the geneCURNA INC·Filed 2019·Granted Jul 11, 2023·1 cites·14 claims
- 0885US10696966B2Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBGCURNA INC·Filed 2015·Granted Jun 30, 2020·2 cites·20 claims
- 0985US10583128B2Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (SCNxA) with small moleculesCOLLARD JOSEPH·Filed 2012·Granted Mar 10, 2020·9 cites·2 claims
- 1085US8957037B2Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factorCOLLARD JOSEPH·Filed 2010·Granted Feb 17, 2015·6 cites·18 claims
- 1185US8153606B2Treatment of apolipoprotein-A1 related diseases by inhibition of natural antisense transcript to apolipoprotein-A1COLLARD JOSEPH·Filed 2009·Granted Apr 10, 2012·19 cites·14 claims
- 1284US10934546B2Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)CURNA INC·Filed 2020·Granted Mar 2, 2021·1 cites·18 claims
- 1384US9902959B2Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXNCURNA INC·Filed 2017·Granted Feb 27, 2018·3 cites·14 claims
- 1484US8962585B2Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63COLLARD JOSEPH·Filed 2010·Granted Feb 24, 2015·6 cites·12 claims
- 1583US10253320B2Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1CURNA INC·Filed 2018·Granted Apr 9, 2019·2 cites·6 claims
- 1682US10487327B2Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factorCURNA INC·Filed 2018·Granted Nov 26, 2019·2 cites·12 claims
- 1781US10793857B2Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNACURNA INC·Filed 2017·Granted Oct 6, 2020·1 cites·10 claims
- 1881US10604755B2Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism geneCURNA INC·Filed 2015·Granted Mar 31, 2020·2 cites·15 claims
- 1981US10337011B2Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21CURNA INC·Filed 2017·Granted Jul 2, 2019·2 cites·10 claims
- 2081US10100315B2Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4CURNA INC·Filed 2017·Granted Oct 16, 2018·2 cites·8 claims
- 2181US9920369B2Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3CURNA INC·Filed 2016·Granted Mar 20, 2018·2 cites·14 claims
- 2281US9920322B2Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGFCURNA INC·Filed 2016·Granted Mar 20, 2018·2 cites·15 claims
- 2381US9902995B2Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1CURNA INC·Filed 2016·Granted Feb 27, 2018·2 cites·14 claims
- 2481US8912157B2Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental geneCOLLARD JOSEPH·Filed 2011·Granted Dec 16, 2014·4 cites·15 claims
- 2580US10563202B2Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)CURNA INC·Filed 2015·Granted Feb 18, 2020·2 cites·13 claims
- 2680US9611477B2Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTPCURNA INC·Filed 2015·Granted Apr 4, 2017·2 cites·16 claims
- 2780US9267136B2Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental geneCURNA INC·Filed 2014·Granted Feb 23, 2016·3 cites·34 claims
- 2880US9074210B2Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNFCOLLARD JOSEPH·Filed 2010·Granted Jul 7, 2015·4 cites·13 claims
- 2979US10221413B2Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2CURNA INC·Filed 2015·Granted Mar 5, 2019·2 cites·15 claims
- 3079US9914923B2Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factorCURNA INC·Filed 2015·Granted Mar 13, 2018·2 cites·10 claims
- 3179US9528110B2Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAPCURNA INC·Filed 2015·Granted Dec 27, 2016·2 cites·16 claims
- 3278US10876117B2Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome geneCURNA INC·Filed 2019·Granted Dec 29, 2020·0 cites·14 claims
- 3378US10113166B2Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activityCURNA INC·Filed 2014·Granted Oct 30, 2018·2 cites·15 claims
- 3478US2022195439A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2021·Application pending·0 cites
- 3577US10337013B2Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1CURNA INC·Filed 2017·Granted Jul 2, 2019·1 cites·9 claims
- 3677US10280421B2Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8CURNA INC·Filed 2017·Granted May 7, 2019·1 cites·11 claims
- 3777US10053691B2Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOGCURNA INC·Filed 2017·Granted Aug 21, 2018·1 cites·14 claims
- 3877US9714423B2Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1CURNA INC·Filed 2014·Granted Jul 25, 2017·2 cites·15 claims
- 3977US9089588B2Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)COLLARD JOSEPH·Filed 2011·Granted Jul 28, 2015·3 cites·12 claims
- 4077US8987225B2Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOGCOLLARD JOSEPH·Filed 2011·Granted Mar 24, 2015·2 cites·15 claims
- 4176US10370657B2Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen geneCURNA INC·Filed 2016·Granted Aug 6, 2019·1 cites·14 claims
- 4276US9708604B2Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1COLLARD JOSEPH·Filed 2010·Granted Jul 18, 2017·2 cites·12 claims
- 4376US8993533B2Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4COLLARD JOSEPH·Filed 2011·Granted Mar 31, 2015·2 cites·14 claims
- 4475US8921334B2Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1COLLARD JOSEPH·Filed 2010·Granted Dec 30, 2014·2 cites·13 claims
- 4574US10358646B2Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the geneCURNA INC·Filed 2014·Granted Jul 23, 2019·1 cites·10 claims
- 4674US9902958B2Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLGCURNA INC·Filed 2016·Granted Feb 27, 2018·1 cites·11 claims
- 4773US11339394B2Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen geneCURNA INC·Filed 2019·Granted May 24, 2022·0 cites·14 claims
- 4873US9155754B2Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1COLLARD JOSEPH·Filed 2010·Granted Oct 13, 2015·1 cites·12 claims
- 4973US8895528B2Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1COLLARD JOSEPH·Filed 2011·Granted Nov 25, 2014·1 cites·15 claims
- 5072US9879264B2Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1CURNA INC·Filed 2015·Granted Jan 30, 2018·1 cites·13 claims
Showing the top 50 of 131 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Joseph Collard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →